Research · Dr. Manu Jaggi
Translational research · Molecule to market

Research

Ten programmes across oncology, drug delivery, regenerative medicine, infection, skin, eye, immunity and biomarker diagnostics, each carried from a formulation idea toward patients.

{{ s.i }} · {{ s.name }}
{{ s.n }}
programmes reached

Where the work happens

Leading research teams, product pipelines and national scientific bodies.

{{ r.role }}{{ r.org }}
{{ it }}

One pipeline, ten programmes

Programme
FormulationPreclinicalHuman trialsMarket
{{ p.n }}
{{ p.short }}
{{ p.area }}
{{ s.n }} {{ s.area }}

{{ s.title }}

{{ s.summary }}

↗{{ o }}
{{ s.footer }}
{{ s.linkLabel }} →
{{ s.cap }}
STEP {{ st.i }}{{ st.t }}{{ st.d }}
{{ g.t }}{{ gi.a }}{{ gi.l }}
10Diagnostics · Systems biology

Biomarker health panels

Molecular signposts that show what is happening inside the body long before symptoms appear

Biomarkers are measurable molecules such as DNA fragments, proteins, enzymes, hormones and metabolites. Even minor shifts in their levels can signal the early stages of disease or a move away from optimal health.

Chronic stress, poor diet and sedentary lifestyles quietly drive inflammation, immune dysfunction and cellular damage. Tracking biomarkers reveals cellular stress, hormonal and metabolic imbalance, immune dysfunction and tissue damage, so prevention and treatment can begin early.

{{ panel.name }}{{ panel.line }}
{{ m.name }}{{ m.count }}
{{ x }}